Cytokine patterns in cancer patients: a review of the correlation between interleukin 6 and prognosis
Open accessAbstract
OBJECTIVE: In tumor patients, IL-6 appears to be one component of a consistent cancer-associated cytokine network resulting in both a systemic immune stimulation and a microenvironment of cancer-induced immune suppression that ultimately protects the cancer cells. IL-6 has been associated with prognosis in cancer patients, but so far a systemical analysis has not been carried out. METHODS: The present meta-analysis studies the relation between IL-6 serum levels and the prognosis of cancer patients in the available clinical literature of 100 articles published between 1993 and 2013 comprising 11,583 patients. RESULTS: The IL-6 serum level was described as significantly correlating with survival in 82/101 series comprising 85.6% of patients (9917/11,583) with 23 different cancer types. A total of 64 studies dichotomized patient cohorts according to various cut-off IL-6 serum levels: in 59/64 of these series corresponding to 94.5% of the reported patients (7694/8142) significant correlations between IL-6 serum level and survival were seen. The median survival of cancer patients had been determined above various cut-off levels of serum IL-6 in 24 dichotomized studies (26 cohorts). There was a highly significant inverse correlation between median survival of the cohorts with IL-6 serum level above cut-off (1272 patients) and their corresponding IL-6 cut-off values (Spearman R -0,48 p= < 0.001) following a linear regression when both parameters were log-transformed (p < 0.001). A significant correlation between increasing serum IL-6 and tumor stage or metastases was described in 39/44 studies and 91% of published patients (4221/4636) where clinical parameters had been specified. CONCLUSIONS: Closely associated with the patient's clinical condition and independent of the cancer histology, the increased IL-6 serum level uniformly appears to correlate with survival as paraneoplastic condition in later cancer stages independent of the cancer type. Modifications of this paraneoplastic immune reaction may offer new therapeutic options in cancer.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
There is a correlation between IL-6 and the prognosis of 23 different cancer types.
“In addition, the correlation between IL-6 and the prognosis of 23 different cancer types was demonstrated (262).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [262]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399 · see citing works
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755 · see citing works
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · see citing works
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873 · see citing works
Chen, W., Jin, W., Hardegen, N. J., Lei, K.-J., Li, L., Marinos, N. J., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,678 · see citing works
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605 · see citing works
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087 · see citing works
The Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,036 · see citing works
Cancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343 · see citing works
Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S.-I., Nakajima, K., Koyama, K., Iwamatsu, A., et al. (1986) · Nature · doi:10.1038/324073a0 · Cited by 2,139 · see citing works
Van Snick, J. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.001345 · Cited by 1,890 · see citing works
Gauldie, J., Richards, C. D., Harnish, D. C., Lansdorp, P. M., & Baumann, H. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7251 · Cited by 1,635 · see citing works
Interleukin-6 family of cytokines and gp130.
Kishimoto, T., Akira, S., Narazaki, M., & Taga, T. (1995) · Blood · doi:10.1182/blood.v86.4.1243.bloodjournal8641243 · Cited by 1,362 · see citing works
Fantini, M. C., Becker, C., Monteleone, G., Pallone, F., Galle, P. R., & Neurath, M. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5149 · Cited by 1,137 · see citing works
Interleukin‐10: new perspectives on an old cytokine
Mosser, D. M., & Zhang, X. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00706.x · Cited by 1,077 · see citing works
Cytokine patterns in patients with cancer: a systematic review
Lippitz, B. E. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70582-x · Cited by 906 · see citing works
Self-citationRole of tumor-associated macrophages in tumor progression and invasion
Mantovani, A., Schioppa, T., Porta, C., Allavena, P., & Sica, A. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9001-7 · Cited by 885 · see citing works
IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation
Kaplanski, G. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(02)00013-3 · Cited by 811 · see citing works
Hurst, S. M., Wilkinson, T. S., McLoughlin, R. M., Jones, S., Horiuchi, S., Yamamoto, N., Rose-John, S., Fuller, G. M., Topley, N., & Jones, S. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00151-0 · Cited by 811 · see citing works
IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer
Neurath, M. F., & Finotto, S. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.02.003 · Cited by 578 · see citing works
Roca, H., Varsos, Z. S., Sud, S., Craig, M. J., Chi, Y., & Pienta, K. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.042671 · Cited by 567 · see citing works
Circulating interleukin‐6 predicts survival in patients with metastatic breast cancer
Salgado, R., Junius, S., Benoy, I. H., van Dam, P. A., Vermeulen, P., Marck, E. V., Huget, P., & Dirix, L. Y. (2002) · International Journal of Cancer · doi:10.1002/ijc.10833 · Cited by 435 · see citing works
Michalaki, V., Syrigos, K., Charles, P., & Waxman, J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601814 · Cited by 406 · see citing works
Interleukin‐6 and its receptor in cancer: Implications for Translational Therapeutics
Hong, D. S., Angelo, L. S., & Kurzrock, R. (2007) · Cancer · doi:10.1002/cncr.22999 · Cited by 370 · see citing works
Serum interleukin‐6 levels reflect the disease status of colorectal cancer
Chung, Y., & Chang, Y. (2003) · Journal of Surgical Oncology · doi:10.1002/jso.10269 · Cited by 354 · see citing works
Serum interleukin 6 as a prognostic factor in patients with prostate cancer.
Nakashima, J., Tachibana, M., Horiguchi, Y., Oya, M., Ohigashi, T., Asakura, H., & Murai, M. (2000) · PubMed · Cited by 351 · see citing works
Negus, R. P. M., Stamp, G. W. H., Hadley, J., & Balkwill, F. R. (1997) · Europe PMC (PubMed Central) · Cited by 341 · see citing works
Interleukin‐6 predicts recurrence and survival among head and neck cancer patients
Duffy, S. A., Taylor, J. M. G., Terrell, J. E., Islam, M., Li, Y., Fowler, K. E., Wolf, G. T., & Teknos, T. N. (2008) · Cancer · doi:10.1002/cncr.23615 · Cited by 330 · see citing works
Involvement of IL–6 in the pathogenesis of inflammatory bowel disease and colon cancer
Atreya, R., & Neurath, M. F. (2005) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:28:3:187 · Cited by 324 · see citing works
Bachelot, T., Ray-Coquard, I., Ménétrier‐Caux, C., Rastkha, M., Duc, A., & Blay, J. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600956 · Cited by 317 · see citing works
Zhang, G.-J., & Adachi, I. (1999) · PubMed · Cited by 308 · see citing works
Interleukin‐6 Trans‐Signalling in Chronic Inflammation and Cancer
Scheller, J., Ohnesorge, N., & Rose‐John, S. (2006) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2006.01750.x · Cited by 301 · see citing works
How much is too much? Interleukin-6 and its signalling in atherosclerosis
Schuett, H., Luchtefeld, M., Grothusen, C., Grote, K., & Schieffer, B. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-05-0297 · Cited by 293 · see citing works
Tran, H. T., Liu, Y., Zurita, A. J., Lin, Y., Baker-Neblett, K. L., Martin, A.-M., Figlin, R. A., Hutson, T. E., Sternberg, C. N., Amado, R. G., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70241-3 · Cited by 258 · see citing works
Marin, V., Montero-Julian, F., Grès, S., Boulay, V., Bongrand, P., Farnarier, C., & Kaplanski, G. (2001) · Journal of Immunology · doi:10.4049/jimmunol.167.6.3435 · Cited by 227 · see citing works
Dominitzki, S., Fantini, M. C., Neufert, C. F., Nikolaev, A., Galle, P. R., Scheller, J., Monteleone, G., Rose‐John, S., Neurath, M. F., & Becker, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2041 · Cited by 226 · see citing works
Interleukin-6 Stimulates Circulating Blood-Derived Endothelial Progenitor Cell Angiogenesis in vitro
Fan, Y., Ye, J., Shen, F., Zhu, Y., Yeghiazarians, Y., Zhu, W. P., Chen, Y., Lawton, M. T., Young, W. L., & Yang, G. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600509 · Cited by 220 · see citing works
Oberholzer, A., Souza, S., Tschoeke, S. K., Oberholzer, C., Abouhamze, A. S., Pribble, J. P., & Moldawer, L. L. (2005) · PubMed · Cited by 219 · see citing works
Bellone, G., Smirne, C., Mauri, F. A., Tonel, E., Carbone, A., Buffolino, A., Dughera, L., Robecchi, A., Pirisi, M., & Emanuelli, G. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0047-0 · Cited by 209 · see citing works
Martı́n, F., Santolaria, F., Batista, N., Milena, A., González‐Reimers, E., Brito, M. J., & Oramás, J. (1999) · Cytokine · doi:10.1006/cyto.1998.0398 · Cited by 207 · see citing works
Cancer‐promoting tumor‐associated macrophages: New vistas and open questions
Mantovani, A., Germano, G., Marchesi, F., Locatelli, M., & Biswas, S. K. (2011) · European Journal of Immunology · doi:10.1002/eji.201141894 · Cited by 205 · see citing works
Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer
Scambia, G., Testa, U., Panici, P. B., Foti, E., Martucci, R., Gadducci, A., Perillo, A., Facchini, V., Peschle, C., & Mancuso, S. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.71 · Cited by 198 · see citing works
Belluco, C., Nitti, D., Frantz, M., Toppan, P., Basso, D., Plebani, M., Lise, M., & Jessup, J. M. (2000) · Annals of Surgical Oncology · doi:10.1007/s10434-000-0133-7 · Cited by 196 · see citing works
Chang, C.-H., Hsiao, C.-F., Yeh, Y.-M., Chang, G., Tsai, Y.-H., Chen, Y.-M., Huang, M.-S., Chen, H.-L., Li, Y.-J., Yang, P.-C., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.27892 · Cited by 187 · see citing works
Kim, D.-K., Oh, S. Y., Kwon, H.-C., Lee, S., Kwon, K. A., Kim, B. G., Kim, S.-G., Kim, S., Jang, J. S., Kim, M. C., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-155 · Cited by 181 · see citing works
Négrier, S., Pérol, D., Ménétrier‐Caux, C., Escudier, B. J., Pallardy, M., Ravaud, A., Douillard, J., Chevreau, C., Lasset, C., & Blay, J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.121 · Cited by 176 · see citing works
Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis
Patel, R. T., Deen, K. I., Youngs, D. J., Warwick, J., & Keighley, M. R. B. (1994) · British journal of surgery · doi:10.1002/bjs.1800810914 · Cited by 172 · see citing works
George, D. J., Halabi, S., Shepard, T. F., Sanford, B. L., Vogelzang, N. J., Small, E. J., & Kantoff, P. W. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1560 · Cited by 168 · see citing works
Kurzrock, R., Redman, J. R., Cabanillas, F., JONES, D. M., Rothberg, J. M., & Talpaz, M. (1993) · PubMed · Cited by 168 · see citing works
Sánchez-Lara, K., Turcott, J. G., Juárez, E., Guevara‐Ramírez, P., Núñez-Valencia, C., Oñate-Ocaña, L. F., Flores, D., & Arrieta, O. G. (2012) · Nutrition and Cancer · doi:10.1080/01635581.2012.668744 · Cited by 164 · see citing works
Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma
Seymour, J. F., Talpaz, M., Cabanillas, F., Wetzler, M., & Kurzrock, R. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.3.575 · Cited by 164 · see citing works
Fujimoto, M., Nakano, M., Terabe, F., Kawahata, H., Ohkawara, T., Han, Y., Ripley, B., Serada, S., Nishikawa, T., Kimura, A., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903314 · Cited by 160 · see citing works
Ashizawa, T., Okada, R., Suzuki, Y., Takagi, M., Yamazaki, T., Sumi, T., Aoki, T., Ohnuma, S., & Aoki, T. (2005) · Gastric Cancer · doi:10.1007/s10120-005-0315-x · Cited by 158 · see citing works
Role of Mononuclear Cells and Inflammatory Cytokines in Pancreatic Cancer-Related Cachexia
Martignoni, M. E., Kunze, P., Hildebrandt, W., Künzli, B. M., Berberat, P. O., Giese, T., Klöters, O., Hammer, J., Büchler, M. W., Giese, N. A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0185 · Cited by 157 · see citing works
Serum IL-6, TNFα and CRP levels in Greek colorectal cancer patients: Prognostic implications
Nikiteas, N. I. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i11.1639 · Cited by 155 · see citing works
Mitsunaga, S., Ikeda, M., Shimizu, S., Ohno, I., Furuse, J., Inagaki, M., Higashi, S., Kato, H., Terao, K., & Ochiai, A. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.174 · Cited by 153 · see citing works
IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus
Chen, M., Chen, P.-T., Lu, M. S., Lin, P. Y., Chen, W., & Lee, K. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-26 · Cited by 150 · see citing works
Serum interleukin-6 levels reflect disease status of gastric cancer.
Wu, C.-H., Wang, S. R., Chao, M. F., Wu, T., Lui, W. Y., Peng, F., & W, C. (1996) · PubMed · Cited by 139 · see citing works
Ren, Y., Tsui, H., Poon, R. T. P., Ng, I. O., Li, Z., Chen, Y., Jiang, G., Lau, C. P.-Y., Yu, W., Bacher, M., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11287 · Cited by 138 · see citing works
Serum Evaluation of Interleukin 6 in Ovarian Cancer Patients
Tempfer, C. M., Zeisler, H., Sliutz, G., Haeusler, G., Hanzal, E., & Kainz, C. (1997) · Gynecologic Oncology · doi:10.1006/gyno.1997.4726 · Cited by 133 · see citing works
Tsimberidou, A. M., Estey, E. H., Wen, S., Pierce, S. A., Kantarjian, H. M., Albitar, M. X., & Kurzrock, R. (2008) · Cancer · doi:10.1002/cncr.23785 · Cited by 132 · see citing works
Afford, S. C., Pongracz, J. E., STOCKLEY, R. A., Crocker, J., & Burnett, D. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36655-4 · Cited by 128 · see citing works
Ravishankaran, P., & Karunanithi, R. (2011) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-9-18 · Cited by 125 · see citing works
Serial cytokine levels in patients with severe sepsis
Wu, H.-P., Chen, C.-K., Chung, K., Tseng, J., Hua, C., Liu, Y., Chuang, D., & Yang, C.-H. (2009) · Inflammation Research · doi:10.1007/s00011-009-0003-0 · Cited by 124 · see citing works
Kaminska, J. A., Kowalska, M. M., Kotowicz, B. U., Fuksiewicz, M., Głogowski, M., Wójcik, E., Chechlińska, M., & Steffen, J. A. (2006) · Oncology · doi:10.1159/000093002 · Cited by 118 · see citing works
Casasnovas, O., Mounier, N., Brice, P., Diviné, M., Morschhauser, F., Gabarre, J., Blay, J., Voillat, L., Lederlin, P., Stamatoullas, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.1331 · Cited by 118 · see citing works
Rutkowski, P. L., Kaminska, J. A., Kowalska, M. M., Ruka, W., & Steffen, J. A. (2003) · Journal of Surgical Oncology · doi:10.1002/jso.10305 · Cited by 117 · see citing works
Kwon, K. A., Kim, S. H., Oh, S. Y., Lee, S., Han, J., Kim, K. H., Goh, R.-Y., Choi, H. J., Park, K., Roh, M. S., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-203 · Cited by 116 · see citing works
Serum interleukin-6 and -10 levels in patients with gastric cancer
Ikeguchi, M., Hatada, T., Yamamoto, M., Miyake, T., Matsunaga, T., Fukumoto, Y., Yamada, Y., Fukuda, K., Saito, H., & Tatebe, S. (2009) · Gastric Cancer · doi:10.1007/s10120-009-0509-8 · Cited by 116 · see citing works
Herbeuval, J., Lelièvre, E., Lambert, C., Dy, M., & Genin, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4630 · Cited by 113 · see citing works
Prognostic value of serum interleukin-6 in diffuse large-cell lymphoma
Preti, H. A., Cabanillas, F., Talpaz, M., Tucker, S. L., Seymour, J. F., & Kurzrock, R. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-3-199708010-00002 · Cited by 112 · see citing works
Serum Concentrations of Cytokines and Lung Cancer Survival in African Americans and Caucasians
Enewold, L., Mechanic, L. E., Bowman, E. D., Zheng, Y., Yu, Z., Trivers, G., Alberg, A. J., & Harris, C. C. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0705 · Cited by 108 · see citing works
Bozcuk, H. S., Uslu, G., Samur, M., Yıldız, M., Özben, T., Özdoğan, M., Artaç, M., Altunbaş, H., Akan, I., & Savaş, B. (2004) · Cytokine · doi:10.1016/j.cyto.2004.04.002 · Cited by 106 · see citing works
Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma
Reynés, G., Vila, V., Martín, M. S., Parada, A., Fleitas, T., Regañón, E., & Martínez‐Sales, V. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0290-x · Cited by 106 · see citing works
Nixon, A. B., Pang, H., Starr, M. D., Friedman, P. N., Bertagnolli, M. M., Kindler, H. L., Goldberg, R. M., Venook, A. P., & Hurwitz, H. I. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0926 · Cited by 104 · see citing works
Mroczko, B., Groblewska, M., Gryko, M., Kędra, B., & Szmitkowski, M. (2010) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.20395 · Cited by 103 · see citing works
Systemic Inflammatory Response Predicts Prognosis in Patients with Advanced-Stage Colorectal Cancer
Sharma, R., Zucknick, M., London, R. M., Kacevska, M., Liddle, C., & Clarke, S. J. (2008) · Clinical Colorectal Cancer · doi:10.3816/ccc.2008.n.044 · Cited by 103 · see citing works
Andrews, B., Shariat, S. F., Kim, J., Wheeler, T. M., Slawin, K. M., & Lerner, S. P. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)65348-7 · Cited by 102 · see citing works
Bruno, R., Sabater, L., Sospedra, M., Ferrer-Francesch, X., Escudero, D., Martínez-Cáceres, E. M., & Pujol‐Borrell, R. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(2002010)32:10 · Cited by 102 · see citing works
Lambeck, A. J. A., Crijns, A. P. G., Leffers, N., Sluiter, W. J., ten Hoor, K. A., Braid, M., van der Zee, A. G. J., Daemen, T., Nijman, H. W., & Kast, W. M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1828 · Cited by 101 · see citing works
PROGNOSTIC VALUE OF CYTOKINES IN SIRS GENERAL MEDICAL PATIENTS
Rodrı́guez-Gaspar, M., Santolaria, F., Jarque-López, A., González‐Reimers, E., Milena, A., de la Vega, M.-J., Rodríguez-Rodríguez, E., & Gómez-Sirvent, J. L. (2001) · Cytokine · doi:10.1006/cyto.2001.0932 · Cited by 100 · see citing works
Rutkowski, P. L., Kaminska, J. A., Kowalska, M. M., Ruka, W., & Steffen, J. A. (2002) · International Journal of Cancer · doi:10.1002/ijc.10496 · Cited by 98 · see citing works
Utech, A. E., Tadros, E. M., Hayes, T. G., & Garcia, J. M. (2012) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-012-0075-5 · Cited by 97 · see citing works
Songür, N., Kuru, B., Kalkan, F., Özdilekcan, Ç., Çakmak, H., & Hızel, N. (2004) · Tumori Journal · doi:10.1177/030089160409000207 · Cited by 96 · see citing works
Vita, F. D., Romano, C. P., Orditura, M., Galizia, G., Martinelli, E., Lieto, E., & Catalano, G. (2001) · Journal of Interferon & Cytokine Research · doi:10.1089/107999001459150 · Cited by 95 · see citing works
Zhang, J., Patel, L. R., & Pienta, K. J. (2010) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385071-3.00003-4 · Cited by 93 · see citing works
Interleukin‐6 serum levels in patients with gynecological tumors
Scambia, G., Testa, U., Panici, P. B., Martucci, R., Foti, E., Petrini, M., Amoroso, M., Masciullo, V., Peschle, C., & Mancuso, S. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570305 · Cited by 93 · see citing works
Mantovani, G., Macciò, A., Madeddu, C., Mura, L., Massa, E., Mudu, M. C., Mulas, C., Lusso, M. R., Gramignano, G., & Piras, M. R. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100234 · Cited by 92 · see citing works
Serum levels of cytokines in patients with untreated primary lung cancer
Department Medical Oncology (1996) · Lung Cancer · doi:10.1016/s0169-5002(96)80030-4 · Cited by 91 · see citing works
Ghani, R. A., ZAINUDIN, S., Kong, N. C. T., RAHMAN, A. F. A., WAFA, S. R. W. S. H., Mohamad, M. S. F., Manaf, M. R. A., & ISMAIL, R. (2006) · Nephrology · doi:10.1111/j.1440-1797.2006.00600.x · Cited by 91 · see citing works
Kimura, A., & Kishimoto, T. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.10.004 · Cited by 90 · see citing works
Groblewska, M., Mroczko, B., Wereszczyńska-Siemiątkowska, U., Kędra, B., Łukaszewicz‐Zając, M., Baniukiewicz, A., & Szmitkowski, M. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.278 · Cited by 88 · see citing works
Niitsu, N., Okamoto, M., Nakamine, H., Yoshino, T., Tamaru, J., Nakamura, S., Higashihara, M., & Hirano, M. (2002) · European Journal Of Haematology · doi:10.1034/j.1600-0609.2002.01609.x · Cited by 88 · see citing works
Inagaki, A., Ishida, T., Ishii, T., Komatsu, H., Iida, S., Ding, J., Yonekura, K., Takeuchi, S., Takatsuka, Y., Utsunomiya, A., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21688 · Cited by 84 · see citing works
Interleukin-6, its role in fibrosing conditions
O’Reilly, S., Ciechomska, M., Cant, R., Hügle, T., & van Laar, J. M. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.04.003 · Cited by 83 · see citing works
Yue, C., You, X., Zhao, L., Wang, H., Tang, F.-L., Zhang, F., Zhang, X., & He, W. (2009) · Rheumatology International · doi:10.1007/s00296-009-1179-x · Cited by 83 · see citing works
Interleukin-6: From identification of the cytokine to development of targeted treatments
Assier, É., Boissier, M., & Dayer, J. (2010) · Joint Bone Spine · doi:10.1016/j.jbspin.2010.07.007 · Cited by 82 · see citing works
Fukuyama, T., Ichiki, Y., Yamada, S., Shigematsu, Y., Baba, T., Nagata, Y., Mizukami, M., Sugaya, M., Takenoyama, M., Hanagiri, T., et al. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00507.x · Cited by 79 · see citing works
Serum levels of interleukin-6 as a prognostic factor in advanced non-small cell lung cancer.
Vita, F. D., Orditura, M., Auriemma, A., Infusino, S., Roscigno, A., & Catalano, G. (1998) · Oncology Reports · doi:10.3892/or.5.3.649 · Cited by 75 · see citing works
Oberije, C., Aerts, H. J. W. L., Yu, S., Ruysscher, D. D., Menheere, P. P. C. A., Hilvo, M., van der Weide, H. L., Rao, B., & Lambin, P. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.06.011 · Cited by 74 · see citing works
Liu, Y., Starr, M. D., Bulusu, A., Pang, H., Wong, N. S., Honeycutt, W., Amara, A., Hurwitz, H. I., & Nixon, A. B. (2013) · Cancer Medicine · doi:10.1002/cam4.71 · Cited by 73 · see citing works
Essential role of IL-6 signaling pathway in keloid pathogenesis.
Ghazizadeh, M. (2007) · Journal of Nippon Medical School = Nippon Ika Daigaku zasshi · doi:10.1272/jnms.74.11 · Cited by 73 · see citing works
Groeneveld, A. B. J., Tacx, A. N., Bossink, A. W. J., van Mierlo, G. J., & Hack, C. E. (2003) · Clinical Immunology · doi:10.1016/s1521-6616(02)00025-6 · Cited by 73 · see citing works
Walther, M. M., JOHNSON, B., CULLEY, D., Shah, R., Weber, J. S., Venzon, D. J., Yang, J. C.-H., Linehan, W. M., & Rosenberg, S. A. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)63709-1 · Cited by 71 · see citing works
Łukaszewicz‐Zając, M., Mroczko, B., Gryko, M., Kędra, B., & Szmitkowski, M. (2010) · Clinical and Experimental Medicine · doi:10.1007/s10238-010-0114-5 · Cited by 69 · see citing works
Monfrecola, G., Gaudiello, F., Cirillo, T., Fabbrocini, G., Balato, A., & Lembo, S. (2013) · Clinical and Experimental Dermatology · doi:10.1111/ced.12018 · Cited by 62 · see citing works
Clinical significance of tissue expression of interleukin-6 in colorectal carcinoma.
Chung, Y., Chaen, Y.-L., & Hsu, C.-P. (2006) · PubMed · Cited by 59 · see citing works
Suh, S., Choi, Y. S., Yeom, C. H., Kwak, S. M., Yoon, H. M., Kim, D. G., Koh, S.-J., Park, J., Lee, M. A., Lee, Y. J., et al. (2013) · Supportive Care in Cancer · doi:10.1007/s00520-013-1878-4 · Cited by 58 · see citing works
Yamamura, M., Yamada, Y., Momita, S., Kamihira, S., & Tomonaga, M. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00538.x · Cited by 58 · see citing works
Serum interleukin-6 as a prognostic biomarker in patients with metastatic melanoma
Hoejberg, L., Bastholt, L., Johansen, J. S., Christensen, I. J., Gehl, J., & Schmidt, H. (2012) · Melanoma Research · doi:10.1097/cmr.0b013e3283550aa5 · Cited by 57 · see citing works
Egler, R. A., Burlingame, S. M., Nuchtern, J. G., & Russell, H. V. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5017 · Cited by 57 · see citing works
Heikkilä, K., Ebrahim, S. B. J., Rumley, A., Lowe, G. D. O., & Lawlor, D. A. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0093 · Cited by 56 · see citing works
Vizio, B., Novarino, A., Giacobino, A., Cristiano, C., Prati, A., Ciuffreda, L., Montrucchio, G., & Bellone, G. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.553 · Cited by 54 · see citing works
Pedersen, L. M., Klausen, T. W., Davidsen, U., & Johnsen, H. E. (2005) · Annals of Hematology · doi:10.1007/s00277-005-1020-x · Cited by 54 · see citing works
Yeh, K., Li, Y., Hsieh, L., Lu, C. H., Chou, W., Liaw, C., Tang, R., & Liao, S. (2010) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyq010 · Cited by 53 · see citing works
Ujiie, H., Tomida, M., Akiyama, H., Nakajima, Y., Okada, D., Yoshino, N., Takiguchi, Y., & Tanzawa, H. (2012) · PubMed · Cited by 53 · see citing works
Viallon, A., Guyomarch, S., Marjollet, O., Berger, C., Carricajo, A., Robert, F., Laporte, S., Lambert, C., Page, Y., Zéni, F., et al. (2008) · European Journal of Emergency Medicine · doi:10.1097/mej.0b013e3280ec539b · Cited by 53 · see citing works
Lamb, G. W. A., McArdle, P., Ramsey, S., McNichol, A., Edwards, J., Aitchison, M., & McMillan, D. C. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07666.x · Cited by 52 · see citing works
Necula, L. G., Chivu‐Economescu, M., Stanciulescu, E.-L., Bleoţu, C., Dima, S., Alexiu, I., Dumitru, A., Constantinescu, G., Popescu, I., & Diaconu, C. C. (2012) · PubMed · Cited by 52 · see citing works
Yoshitomi, M., Yutani, S., Matsueda, S., Ioji, T., Komatsu, N., Shichijo, S., Yamada, A., Itoh, K., Sasada, T., & Kinoshita, H. (2011) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2011.424 · Cited by 51 · see citing works
High Serum Interleukin-6 Levels Correlate with a Shorter Failure-Free Survival in Indolent Lymphoma
Fayad, L., Cabanillas, F., Talpaz, M., McLaughlin, P. J., & Kurzrock, R. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809057568 · Cited by 50 · see citing works
Yoon, J., Lafarge, S. T., Dawe, D. E., Lakhi, S., Kumar, R., Morales, C., Marshall, A. J., Gibson, S. B., & Johnston, J. B. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.666662 · Cited by 48 · see citing works
Łukaszewicz‐Zając, M., Mroczko, B., Kozłowski, M., Nikliński, J., Laudanski, J., & Szmitkowski, M. (2011) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2011.01242.x · Cited by 48 · see citing works
Validation of prognostic scores for survival in cancer patients beyond first-line therapy
Trédan, O., Ray-Coquard, I. L., Chvetzoff, G., Rebattu, P., Bajard, A., Chabaud, S., Pérol, D., Saba, C., Quiblier, F., Blay, J., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-95 · Cited by 46 · see citing works
Giachelia, M., Voso, M. T., Tisi, M. C., Martini, M., Bozzoli, V., Massini, G., D’Alò, F., Larocca, L. M., Leone, G. G. M., & Hohaus, S. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2011.621566 · Cited by 46 · see citing works
IL-6 and VEGF in small cell lung cancer patients.
Wójcik, E., Jakubowicz, J., Skotnicki, P., Sas-Korczyńska, B., & Kulpa, J. (2010) · PubMed · Cited by 45 · see citing works
Serum cytokines in follicular lymphoma. Correlation of TGF-β and VEGF with survival
Labidi‐Galy, S. I., Ménétrier‐Caux, C., Chabaud, S., Chassagne, C., Sebban, C., Gargi, T., Biron, P., Blay, J., & Ghesquières, H. (2009) · Annals of Hematology · doi:10.1007/s00277-009-0777-8 · Cited by 44 · see citing works
Shimazaki, J., Goto, Y., Nishida, K., Tabuchi, T., Motohashi, G., Ubukata, H., & Tabuchi, T. (2013) · Oncology · doi:10.1159/000350836 · Cited by 44 · see citing works
Guida, M., CASAMASSIMA, A., Monticelli, G., Quaranta, M., & Colucci, G. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-51 · Cited by 43 · see citing works
Far, M. E., Fouda, M., Yahya, R. S., & Baz, H. E. (2004) · Journal of Physiology and Biochemistry · doi:10.1007/bf03167070 · Cited by 42 · see citing works
Koh, E., Iizasa, T., Yamaji, H., Sekine, Y., Hiroshima, K., Yoshino, I., & Fujisawa, T. (2012) · International Journal of Surgical Pathology · doi:10.1177/1066896911436274 · Cited by 41 · see citing works
Soubrane, C., Rixe, O., Méric, J., Khayat, D., & Mouawad, R. (2005) · Melanoma Research · doi:10.1097/00008390-200506000-00009 · Cited by 41 · see citing works
Fabre, E., Tabrizi, R., Coulon, V., Monnereau, A., Eghbali, H., Soubeyran, I., & Soubeyran, P. (2005) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190500361029 · Cited by 41 · see citing works
Influence of p53 status on prognosis in preoperatively irradiated rectal carcinoma
Nehls, O., Klump, B., Holzmann, K., Lammering, G., Borchard, F., Gruenagel, H. H., Gaco, V., Gregor, M., & Porschen, R. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990615)85:12 · Cited by 38 · see citing works
Arshad, A. R., Chung, W. Y., Steward, W. P., Metcalfe, M. S., & Dennison, A. R. (2012) · HPB · doi:10.1111/hpb.12002 · Cited by 38 · see citing works
Taş, F., Oğuz, H., Argon, A., Duranyıldız, D., Çamlıca, H., Yasasever, V., & Topuz, E. (2005) · Medical Oncology · doi:10.1385/mo:22:3:241 · Cited by 37 · see citing works
Kita, H., Shiraishi, Y., Watanabe, K., Suda, K., Ohtsuka, K., Koshiishi, Y., & Goya, T. (2011) · Annals of Thoracic and Cardiovascular Surgery · doi:10.5761/atcs.oa.10.01627 · Cited by 37 · see citing works
Schultz, N. A., Christensen, I. J., Werner, J., Giese, N. A., Jensen, B. V., Larsen, O. F., Bjerregaard, J. K., Pfeiffer, P., Calatayud, D., Nielsen, S. E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067059 · Cited by 35 · see citing works
Montero, A. J., Diaz-Montero, C. M., Millikan, R. E., Liu, J., Do, K.-A., Hodges, S., Jonasch, E. W., McIntyre, B. W., Hwu, P., & Tannir, N. M. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp054 · Cited by 35 · see citing works
Prognostic value of interleukin-6 and interleukin-8 in laryngeal squamous cell cancer
Hao, W., Zhu, Y., & Zhou, H. (2012) · Medical Oncology · doi:10.1007/s12032-012-0333-6 · Cited by 32 · see citing works
Dean-Colomb, W. M., Hess, K. R., Young, E. J., Gornet, T. G., Handy, B. C., Moulder, S. L., Ibrahim, N. K., Pusztai, L., Booser, D. J., Valero, V., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2374-0 · Cited by 31 · see citing works
Cândido, E. B., Silva, L. M., Teixeira‐Carvalho, A., Lamaita, R. M., Filho, R. M. P., Cota, B. D. C. V., & Filho, A. L. D. S. (2012) · Reproductive Sciences · doi:10.1177/1933719112466299 · Cited by 30 · see citing works
Intravenous Tocilizumab: A Review of Its Use in Adults with Rheumatoid Arthritis
Dhillon, S. (2013) · BioDrugs · doi:10.1007/s40259-013-0076-8 · Cited by 30 · see citing works
Duletić‐Načinović, A., Štifter, S., Marijić, B., Lučin, K., Valković, T., Petranović, D., & Jonjić, N. (2008) · Tumori Journal · doi:10.1177/030089160809400412 · Cited by 27 · see citing works
Su, C., Zhou, C., Zhou, S., & Xu, J. (2010) · Medical Oncology · doi:10.1007/s12032-010-9645-6 · Cited by 27 · see citing works
Chow, K., Chiou, S.-H., Ho, S.-P., Tsai, M.-H., Chen, C., Wang, L.-S., & Chi, K.-H. (2003) · Oncology Reports · doi:10.3892/or.10.4.813 · Cited by 27 · see citing works
Interleukin-1 beta and interleukin-6 release by peripheral blood monocytes in head and neck cancer
Gallo, O., Gori, A. M., Attanasio, M., Martini, F., Giusti, B., Boddi, M., Gallina, E., Fini, O., & Abbate, R. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.371 · Cited by 26 · see citing works
Parameters of biological activity in colorectal cancer.
Svobodová, Š., Topolčan, O., Holubec, L., Levý, M., Pecen, L., & Svacina, S. (2011) · PubMed · Cited by 26 · see citing works
Soluble immunological parameters and early prognosis of renal cell cancer patients.
KALLIO, J. P., Tammela, T. L. J., Marttinen, A. T., & Kellokumpu‐Lehtinen, P. (2001) · PubMed · Cited by 25 · see citing works
Fuksiewicz, M., Kowalska, M. M., Kotowicz, B. U., Rubach, M., Chechlińska, M., Pieńkowski, T., & Kaminska, J. A. (2010) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2010.278 · Cited by 20 · see citing works
IL-6 and IFN-γ regulation of IL-10 production by human colon carcinoma cells
Suzuki, S., Mita, S., Kamohara, H., Sakamoto, K., Ishiko, T., & Ogawa, M. (2001) · International Journal of Oncology · doi:10.3892/ijo.18.3.581 · Cited by 20 · see citing works
Özdemir, F., Aydın, F., Yılmaz, M., Kavgacı, H., Bektas, O., Mn, Y., & Aa, Y. (2004) · PubMed · Cited by 20 · see citing works
Plasma cytokine and P‐selectin levels in advanced malignancy
Nisio, M. D., Niers, T. M. H., Reitsma, P. H., & Buller, H. R. (2005) · Cancer · doi:10.1002/cncr.21485 · Cited by 18 · see citing works
Following up tumor-specific regulatory T cells in cancer patients
Zitvogel, L., Tanchot, C., Granier, C., & Tartour, É. (2013) · OncoImmunology · doi:10.4161/onci.25444 · Cited by 18 · see citing works
The value of serum S-100β and interleukins as tumour markers in advanced melanoma
Vuoristo, M.-S., Kellokumpu-Lehtinen, P., Laine, S., Parvinen, L.-M., Hahka‐Kemppinen, M., Korpela, M., & Kumpulainen, E. (2000) · Melanoma Research · doi:10.1097/00008390-200006000-00005 · Cited by 18 · see citing works
Contact stimulation of fibroblasts for tenascin production by melanoma cells
Ádám, B., Tóth, L., Pásti, G., Balázs, M., & Ádány, R. (2006) · Melanoma Research · doi:10.1097/01.cmr.0000205022.25397.86 · Cited by 17 · see citing works
Grim-Stieger, M., Keilani, M. Y., Mader, R. M., Marosi, C., Schmidinger, M., Zielinski, C. C., Fialka‐Moser, V., & Crevenna, R. (2008) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2007.00874.x · Cited by 15 · see citing works
Thomas, X., Hirschauer, C., Troncy, J., Assouline, D., Joly, M., Fiere, D. M., & Archimbaud, E. (1997) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199709039016 · Cited by 14 · see citing works
Ramsey, S., Aitchison, M., Graham, J., & McMillan, D. C. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07466.x · Cited by 14 · see citing works
The value of serum S-100β and interleukins as tumour markers in advanced melanoma
Vuoristo, M.-S., Kellokumpu-Lehtinen, P., Laine, S., et al. (2000) · Melanoma Research · doi:10.1097/00008390-200010030-00005 · Cited by 14 · see citing works
Guida, M., Riccobon, A., Biasco, G., Ravaioli, A., CASAMASSIMA, A., Freschi, A., Palma, M. D., Galligioni, E., Nortilli, R., Chiarion‐Sileni, V., et al. (2006) · Melanoma Research · doi:10.1097/01.cmr.0000200491.00841.5f · Cited by 9 · see citing works
Wang, Y., Miao, L., Liu, L., Cai, H., Ding, J., Ren, S., Zhou, C., & Schmid‐Bindert, G. (2013) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20130578 · Cited by 8 · see citing works
Parameter der frühen Prädiktion des Sepsisverlaufs
Novotny, A., Emmanuel, K., Bartels, H., Siewert, J. R., & Holzmann, B. (2005) · Der Chirurg · doi:10.1007/s00104-005-1077-z · Cited by 7 · see citing works
Prognostic potential of cytokines, nitrates, and APACHE II score in sepsis.
Bencosme, A., Warner, A. M., Healy, D. P., & Verme-Gibboney, C. N. (1996) · PubMed · Cited by 7 · see citing works
Favaro, D., Santarosa, M., Quaia, M., & Galligioni, E. (1997) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/s1078-1439(97)00036-7 · Cited by 6 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [152]Mouawad R, Soubrane C, Rixe O, Khayat D, Spano JP. An unexpected inverse correlation between soluble epidermal growth factor receptor and interleukin-6 in metastatic malignant melanoma patients. Melanoma Res 2006; 16: 335- 40; PMID:16845329 16845329
Cited by
Sorted by citations
IL-6 in inflammation, autoimmunity and cancer
Hirano, T. (2021) · International Immunology · doi:10.1093/intimm/dxaa078 · Cited by 1,453 · see citing works
“In addition, the correlation between IL-6 and the prognosis of 23 different cancer types was demonstrated (262).”
BackgroundC-Reactive Protein and Cancer—Diagnostic and Therapeutic Insights
Hart, P. C., Rajab, I. M., Alebraheem, M., & Potempa, L. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.595835 · Cited by 285 · see citing works
New therapeutic perspectives to manage refractory immune checkpoint-related toxicities
Martins, F., Sykiotis, G. P., Maillard, M. H., Fraga, M. C., Ribi, C., Küntzer, T., Michielin, O. A., Peters, S., Coukos, G., Spertini, F., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30828-3 · Cited by 190 · see citing works
Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies
Davis, J. S., Ferreira, D., Paige, E. K., Gedye, C. A., & Boyle, M. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00035-19 · Cited by 188 · see citing works
Jin, Y. T., Kang, Y., Wang, M., Wu, B., Su, B., Yin, H., Tang, Y., Li, Q., Wei, W., Mei, Q., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00872-9 · Cited by 169 · see citing works
Qiao, Y., Zhang, C., Li, A., Wang, D., Luo, Z., Yü, P., Zhou, B., Liu, S., Li, H., Yue, D., et al. (2017) · Oncogene · doi:10.1038/onc.2017.387 · Cited by 165 · see citing works
Vainer, N., Dehlendorff, C., & Johansen, J. S. (2018) · Oncotarget · doi:10.18632/oncotarget.25661 · Cited by 153 · see citing works
Kwekkeboom, K. L., Tostrud, L. J., Costanzo, E. S., Coe, C. L., Serlin, R. C., Ward, S. E., & Zhang, Y. (2018) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2018.01.008 · Cited by 146 · see citing works
Prognostic role of neutrophil‐to‐lymphocyte ratio in head and neck cancer: A meta‐analysis
Takenaka, Y., Oya, R., Kitamiura, T., Ashida, N., Shimizu, K., Takemura, K., Yamamoto, Y., & Uno, A. (2017) · Head & Neck · doi:10.1002/hed.24986 · Cited by 137 · see citing works
Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?
Hilmi, M., Bartholin, L., & Neuzillet, C. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i20.2137 · Cited by 124 · see citing works
Tengesdal, I. W., Dinarello, A., Powers, N. E., Burchill, M. A., Joosten, L. A. B., Marchetti, C., & Dinarello, C. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.661323 · Cited by 121 · see citing works
Serum levels of IL-6, IL-8, and IL-10 are indicators of prognosis in pancreatic cancer
Feng, L., Qi, Q., Wang, P., Chen, H., Chen, Z., Meng, Z., & Liu, L. (2018) · Journal of International Medical Research · doi:10.1177/0300060518800588 · Cited by 113 · see citing works
MacDonald, W., Purcell, C., Pinho-Schwermann, M. P., Stubbs, N. M., Srinivasan, P. R., & El‐Deiry, W. S. (2025) · Cancers · doi:10.3390/cancers17030441 · Cited by 110 · see citing works
IL-27, IL-30, and IL-35: A Cytokine Triumvirate in Cancer
Kourko, O., Seaver, K., Odoardi, N., Basta, S., & Gee, K. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00969 · Cited by 94 · see citing works
A systematic review examining the relationship between cytokines and cachexia in incurable cancer
Pavăl, D. R., Patton, R., McDonald, J. J., Skipworth, R. J. E., Gallagher, I. J., Laird, B. J. A., & Collaborative, T. C. C. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12912 · Cited by 93 · see citing works
Modulation of megakaryopoiesis and platelet production during inflammation.
Couldwell, G. C., & Machlus, K. (2019) · Thrombosis Research · doi:10.1016/j.thromres.2019.05.008 · Cited by 88 · see citing works
Colorectal carcinoma in the course of inflammatory bowel diseases
Hnatyszyn, A., Hryhorowicz, S., Kaczmarek-Ryś, M., Lis, E., Słomski, R., Scott, R. J., & Pławski, A. (2019) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-019-0118-4 · Cited by 90 · see citing works
Befriending the Hostile Tumor Microenvironment in CAR T-Cell Therapy
Lindo, L., Wilkinson, L., & Hay, K. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.618387 · Cited by 88 · see citing works
Horisberger, A., La Rosa, S., Zurcher, J.-P., Zimmermann, S., Spertini, F., Coukos, G., & Obeid, M. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0481-0 · Cited by 81 · see citing works
Vlahopoulos, S. (2017) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2017.0029 · Cited by 81 · see citing works
El‐Khateeb, E., Achour, B., Al‐Majdoub, Z. M., Barber, J., & Rostami‐Hodjegan, A. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00462 · Cited by 75 · see citing works
Mao, S., Yu, X., Shan, Y., Fan, R., Wu, S., & Lu, C. (2021) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s339707 · Cited by 70 · see citing works
Resveratrol and Tumor Microenvironment: Mechanistic Basis and Therapeutic Targets
Talib, W. H., Alsayed, A. R., Farhan, F., & Kury, L. T. A. (2020) · Molecules · doi:10.3390/molecules25184282 · Cited by 67 · see citing works
Interleukin-6 serves as a critical factor in various cancer progression and therapy
Mohamed, A. H., Ahmed, A. T., Abdulmonem, W. A., Bokov, D. O., Shafie, A., Al‐Hetty, H. R. A. K., Hsu, C., Alissa, M., Nazir, S., Jamali, M. C., et al. (2024) · Medical Oncology · doi:10.1007/s12032-024-02422-5 · Cited by 68 · see citing works
Elie, B. T., Pechenyy, Y., Uddin, F. Z., & Contel, M. (2018) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-018-1546-8 · Cited by 65 · see citing works
Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways
Esparza-López, J., Alvarado-Muñoz, J., Escobar-Arriaga, E., Ulloa-Aguirre, A., & Ibarra-Sánchez, M. D. J. (2019) · BMC Cancer · doi:10.1186/s12885-019-5945-1 · Cited by 49 · see citing works
Multiple cytokine profiling in serum for early detection of gastric cancer
Li, J., Xu, L., Run, Z., Feng, W., Liu, W., Zhang, P., & Li, Z. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i21.2269 · Cited by 60 · see citing works
The therapeutic potential of resveratrol in a mouse model of melanoma lung metastasis
Davoodvandi, A., Darvish, M., Borran, S., Nejati, M., Mazaheri, S., Tamtaji, O. R., Hamblin, M. R., Masoudian, N., & Mirzaei, H. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106905 · Cited by 60 · see citing works
Perioperative Immunosuppressive Factors during Cancer Surgery: An Updated Review
Bezu, L., Öksüz, D. A., Bell, M., Buggy, D. J., Díaz‐Cambronero, Ó., Enlund, M., Forget, P., Gupta, A. K., Hollmann, M. W., Ionescu, D. C., et al. (2024) · Cancers · doi:10.3390/cancers16132304 · Cited by 59 · see citing works
Advancing electrochemical biosensors for interleukin-6 detection
McCrae, L. E., Ting, W., & Howlader, M. M. R. (2022) · Biosensors and Bioelectronics X · doi:10.1016/j.biosx.2022.100288 · Cited by 55 · see citing works
Inflammation and cancer: friend or foe?
Smith, A. D. T., Córdoba-Hernandez, S., Mejía-Guarnizo, L. V., Monroy-Camacho, P. S., & Rodríguez-García, J. A. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1385479 · Cited by 53 · see citing works
The Head and Neck Squamous Cell Carcinoma Microenvironment as a Potential Target for Cancer Therapy
Plzák, J., Bouček, J., Bandúrová, V., Kolář, M., Hradilová, M., Szabó, P., Lacina, L., Chovanec, M., & Smetana, K. (2019) · Cancers · doi:10.3390/cancers11040440 · Cited by 49 · see citing works
A wearable graphene transistor-based biosensor for monitoring IL-6 biomarker
Laliberte, K. E., Scott, P., Khan, N. I., Mahmud, M. S., & Song, E. (2022) · Microelectronic Engineering · doi:10.1016/j.mee.2022.111835 · Cited by 48 · see citing works
A Comprehensive Analysis of Cytokine Network in Centenarians
Pinti, M., Gibellini, L., Tartaro, D. L., Biasi, S. D., Nasi, M., Borella, R., Fidanza, L., Neroni, A., Troiano, L., Franceschi, C., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032719 · Cited by 48 · see citing works
A Facile Graphene Conductive Polymer Paper Based Biosensor for Dopamine, TNF-α, and IL-6 Detection
Rahman, M. A., Pal, R. K., Islam, N., Freeman, R., Francois Berthiaume, B., Mazzeo, A. D., & Ashraf, A. (2023) · Sensors · doi:10.3390/s23198115 · Cited by 46 · see citing works
Song, W., Tian, C., Wang, K., Zhang, R.-J., & Zou, S. (2017) · Scientific Reports · doi:10.1038/srep46601 · Cited by 46 · see citing works
Sreenivasan, L., Wang, H., Yap, S. Q., Leclair, P., Tam, A., & Lim, C. J. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03241-y · Cited by 45 · see citing works
Pundir, M., Papagerakis, S. M., Rosa, M. C. D., Chronis, N., Kurabayashi, K., Abdulmawjood, S., Prince, M. E. P., Lobanova, L., Chen, D., & Papagerakis, P. (2022) · Biotechnology Advances · doi:10.1016/j.biotechadv.2022.107961 · Cited by 44 · see citing works
Tenuta, M., Gelibter, A. J., Pandozzi, C., Sirgiovanni, G., Campolo, F., Venneri, M. A., Caponnetto, S., Cortesi, E., Marchetti, P., Isidori, A. M., et al. (2021) · Cancers · doi:10.3390/cancers13246355 · Cited by 44 · see citing works
Utz, V. E. M., Visñuk, D. P., Perdigón, G., & de LeBlanc, A. D. M. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-11007-x · Cited by 43 · see citing works
Nada, H., Sivaraman, A., Lu, Q., Min, K. H., Kim, S.-D., Goo, J., Choi, Y., & Lee, K. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01957 · Cited by 42 · see citing works
Yaw, A. C. K., Chan, E. W. L., Yap, J. K. Y., & Mai, C. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03274-y · Cited by 42 · see citing works
Role of the parasympathetic nervous system in cancer initiation and progression
Tibenský, M., & Mravec, B. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02465-w · Cited by 42 · see citing works
Inglis, J. E., Kleckner, A. S., Lin, P., Gilmore, N. J., Culakova, E., VanderWoude, A., Mustian, K. M., Fernandez, I. D., Dunne, R. F., Deutsch, J. M., et al. (2020) · Nutrition and Cancer · doi:10.1080/01635581.2020.1807574 · Cited by 43 · see citing works
Srivastava, A., Dixit, A. B., Paul, D., Tripathi, M., Sarkar, C., Chandra, P. S., & Banerjee, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-16041-w · Cited by 39 · see citing works
Choi, H. S., Kim, J. H., Kim, S., & Lee, D. (2019) · Cells · doi:10.3390/cells8091007 · Cited by 39 · see citing works
Lan, M., Lü, W., Zou, T., Li, L., Liu, F., Cai, T., & Cai, Y. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03696-4 · Cited by 39 · see citing works
Doğan, S., Ray, A., & Cleary, M. P. (2017) · Meta Gene · doi:10.1016/j.mgene.2016.12.013 · Cited by 38 · see citing works
Cameron, J. M., Rinaldi, C., Butler, H. J., Hegarty, M. G., Brennan, P. M., Jenkinson, M. D., Syed, K. W., Ashton, K. M., Dawson, T., Palmer, D. S., et al. (2020) · Cancers · doi:10.3390/cancers12071710 · Cited by 38 · see citing works
Quan, Z., He, Y., Luo, C., Xia, Y., Zhao, Y. F., Liu, N., & Wu, X. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.01.017 · Cited by 37 · see citing works
Haffa, M., Holowatyj, A. N., Kratz, M., Tóth, R., Benner, A., Gigic, B., Habermann, N., Schrotz‐King, P., Böhm, J., Brenner, H., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00461 · Cited by 36 · see citing works
Aging, Social Distancing, and COVID-19 Risk: Who is more Vulnerable and Why?
Faraji, J., & Metz, G. A. S. (2021) · Aging and Disease · doi:10.14336/ad.2021.0319 · Cited by 40 · see citing works
Dibaba, D. T., Judd, S. E., Gilchrist, S. C., Cushman, M., Pisu, M., Safford, M. M., & Akinyemiju, T. (2019) · Metabolism · doi:10.1016/j.metabol.2019.01.007 · Cited by 36 · see citing works
Serum IL6 as a Prognostic Biomarker and IL6R as a Therapeutic Target in Biliary Tract Cancers
Høgdall, D., O’Rourke, C. J., Dehlendorff, C., Larsen, O. F., Jensen, L. H., Johansen, A. Z., Dang, H. T., Factor, V. M., Grunnet, M., Mau‐Sørensen, M., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2700 · Cited by 36 · see citing works
Targeting interleukin 6 signaling by monoclonal antibody siltuximab on cholangiocarcinoma
Nguyen, M. L. T., Bùi, K. C., Scholta, T., Xing, J., Bhuria, V., Sipos, B., Wilkens, L., Toàn, N. L., Velavan, T. P., Bozko, P. M., et al. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15307 · Cited by 36 · see citing works
Serum Levels of the IL-6 Family of Cytokines Predict Prognosis in Renal Cell Carcinoma (RCC)
Gudbrandsdottir, G., Aarstad, H. H., Bostad, L., Hjelle, K. M., Aarstad, H. J., Bruserud, Ø., Tvedt, T. H. A., & Beisland, C. (2021) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-020-02655-z · Cited by 35 · see citing works
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers
Chianca, M., Panichella, G., Fabiani, I., Giannoni, A., L’Abbate, S., Aimo, A., Franco, A. D., Vergaro, G., Grigoratos, C., Castiglione, V., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.936654 · Cited by 32 · see citing works
Mahjoor, M., Afkhami, H., Najafi, M., Nasr, A., & Khorrami, S. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04123-w · Cited by 32 · see citing works
The diagnostic and prognostic value of interleukin-6 in patients with soft tissue sarcomas
Hagi, T., Nakamura, T., Iino, T., Matsubara, T., Asanuma, K., Matsumine, A., & Sudo, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-08781-6 · Cited by 32 · see citing works
Armer, J. S., Clevenger, L., Davis, L. Z., Cuneo, M. G., Thaker, P. H., Goodheart, M. J., Bender, D., Dahmoush, L., Sood, A. K., Cole, S. W., et al. (2018) · Cancer · doi:10.1002/cncr.31570 · Cited by 31 · see citing works
Wound Healing Fluid Reflects the Inflammatory Nature and Aggressiveness of Breast Tumors
Agresti, R., Triulzi, T., Sasso, M., Ghirelli, C., Aiello, P., Rybińska, I., Campiglio, M., Sfondrini, L., Tagliabue, E., & Bianchi, F. (2019) · Cells · doi:10.3390/cells8020181 · Cited by 31 · see citing works
Çehreli, R., Yavuzşen, T., Ateş, H., Akman, T., Ellıdokuz, H., & Öztop, İ. (2019) · BioMed Research International · doi:10.1155/2019/1648072 · Cited by 30 · see citing works
Balsano, R., Kruize, Z., Lunardi, M., Comandatore, A., Barone, M., Cavazzoni, A., Cecconi, A. D. R., Morelli, L., Wilmink, H., Tiseo, M., et al. (2022) · Cells · doi:10.3390/cells11172671 · Cited by 27 · see citing works
Increased expression of interleukin-6 gene in gastritis and gastric cancer
dos Santos, M. P., Pereira, J., Delabio, R., Smith, M. D. A. C., Payão, S. L. M., Carneiro, L. C., Barbosa, M. S., & Rasmussen, L. T. (2021) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2020e10687 · Cited by 29 · see citing works
Mihăilă, R. I., Gheorghe, A. S., Zob, D., & Stănculeanu, D. L. (2024) · Biomedicines · doi:10.3390/biomedicines12092146 · Cited by 27 · see citing works
Gilmore, N. J., Kadambi, S. G., Lei, L., Loh, K. P., Mohamed, M., Magnuson, A. M., Cole, S. K., Esparaz, B. T., Giguere, J. K., Mohile, S. G., et al. (2019) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2019.04.001 · Cited by 28 · see citing works
Sensitive Raman detection of human recombinant interleukin-6 mediated by DCDR/GERS hybrid platforms
de la O-Cuevas, E., Badillo‐Ramírez, I., Islas, S. R., Araujo-Andrade, C., & Saniger, J. M. (2019) · RSC Advances · doi:10.1039/c9ra01396b · Cited by 27 · see citing works
Wu, J., Yang, H.-T., Ho, T., Shun, S., & Lin, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040543 · Cited by 26 · see citing works
Peltonen, R., Gramkow, M. H., Dehlendorff, C., Osterlund, P. J., Johansen, J. S., & Isoniemi, H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236569 · Cited by 26 · see citing works
Guo, X., Wang, W., Yuan, X., Yang, Y., Tian, Q., Xiang, Y., Sun, Y. P., & Bai, Z. (2018) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2018.10.095 · Cited by 25 · see citing works
Yang, X.-T., Niu, P., Li, X.-F., Sun, M., Wei, W., Chen, Y., & Zheng, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-58407-x · Cited by 25 · see citing works
Frey, A., Martin, D., D’Cruz, L. A., Fokas, E., Rödel, C. M., & Fleischmann, M. (2022) · Biomedicines · doi:10.3390/biomedicines10030598 · Cited by 25 · see citing works
Ismael, M. N., Forde, J. J., Milla, E., Khan, W., & Cabrera, R. (2019) · BioMed Research International · doi:10.1155/2019/7284040 · Cited by 25 · see citing works
Exploring Novel Frontiers: Leveraging STAT3 Signaling for Advanced Cancer Therapeutics
Adesoye, T., Tripathy, D., Hunt, K. K., & Keyomarsi, K. (2024) · Cancers · doi:10.3390/cancers16030492 · Cited by 24 · see citing works
Pharmacokinetics under the COVID‐19 storm
Reddy, V. P., El‐Khateeb, E., Jo, H., Giovino, N., Lythgoe, E., Sharma, S., Tang, W., Jamei, M., & Rostami‐Hodjegan, A. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14668 · Cited by 23 · see citing works
Dolin, T. G., Christensen, I. J., Johansen, A. Z., Nielsen, H. J., Jakobsen, H. L., Klein, M. F., Lund, C. M., Bojesen, S. E., Nielsen, D. L., Jensen, B., et al. (2021) · Cancers · doi:10.3390/cancers14010161 · Cited by 23 · see citing works
Chen, K., Jones, H. M., & Gill, K. L. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.122.000926 · Cited by 23 · see citing works
Maher, S., ElmelIgy, H. A., Aboushousha, T., Helal, N. S., Ossama, Y., Rady, M., Hassan, A. M. A., & Kamel, M. M. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03686-6 · Cited by 23 · see citing works
Wang, C., Xiao, Q., Wang, J., Yang, J., Chen, Y., Qiao, Y., Guan, Y., Wen, A., & Jiang, L. (2022) · European Journal of Inflammation · doi:10.1177/20587392211069771 · Cited by 22 · see citing works
Ljøkjel, B., Haave, H., Lybak, S., Vintermyr, O. K., Helgeland, L., & Aarstad, H. J. (2022) · Cancers · doi:10.3390/cancers14061508 · Cited by 22 · see citing works
Nakamura, K., Nakamura, T., Iino, T., Hagi, T., Kita, K., Asanuma, K., & Sudo, A. (2020) · Cancers · doi:10.3390/cancers12030585 · Cited by 21 · see citing works
Sang, Y. B., Yang, H., Lee, W. S., Lee, S. J., Kim, S., Cheon, J., Kang, B., Kim, C. W., Chon, H. J., & Kim, C. (2022) · Cancers · doi:10.3390/cancers14235985 · Cited by 21 · see citing works
Song, Q., Wu, J., Wang, S., & Chen, W. (2019) · Scientific Reports · doi:10.1038/s41598-019-51675-y · Cited by 21 · see citing works
Immune Cell Subtypes and Cytokines in Lung Tumor Microenvironment: Influence of COPD
Tang, J., Ramis‐Cabrer, D., Curull, V., Wang, X., Qin, L., Mateu-Jiménez, M., Durán, X., Pijuán, L., Rodríguez-Fuster, A., Aguiló, R., et al. (2020) · Cancers · doi:10.3390/cancers12051217 · Cited by 21 · see citing works
Virgilio, T., Bordini, J., Cascione, L., Sartori, G., Latino, I., Romero, D. M., Leoni, C., Akhmedov, M., Rinaldi, A., Arribas, A. J., et al. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0225 · Cited by 20 · see citing works
Applying Serum Cytokine Levels to Predict Pain Severity in Cancer Patients
Fazzari, J., Sidhu, J., Motkur, S., Inman, M. D., Buckley, N., Clemons, M. J., Vandermeer, L., & Singh, G. (2020) · Journal of Pain Research · doi:10.2147/jpr.s227175 · Cited by 20 · see citing works
Wang, W., McDonald, M. C. L., Hariprasad, R., Hamilton, T., & Frank, D. A. (2024) · Cancers · doi:10.3390/cancers16071387 · Cited by 19 · see citing works
Xu, X., Liu, X., Long, J., Hu, Z., Zheng, Q., Zhang, C., Li, L., Wang, Y., Jia, Y., Qiu, W., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172523 · Cited by 19 · see citing works
Inomata, M., Hirai, T., Seto, Z., Tokui, K., Taka, C., Okazawa, S., Kambara, K., Ichikawa, T., Imanishi, S., Yamada, T., et al. (2018) · Pathology & Oncology Research · doi:10.1007/s12253-018-0473-x · Cited by 19 · see citing works
Liang, B., Li, L., Miao, R., Wang, J., Chen, Y., Li, Z., Zou, X., & Zhou, M. (2019) · Cancer Investigation · doi:10.1080/07357907.2019.1597103 · Cited by 19 · see citing works
Palmquist, C., Dehlendorff, C., Calatayud, D., Hansen, C. P., Hasselby, J. P., & Johansen, J. S. (2019) · Pancreas · doi:10.1097/mpa.0000000000001466 · Cited by 19 · see citing works
Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery
de Sousa, E., Lérias, J. R., Antonio Lopez-beltran, B., Paraschoudi, G., Condeço, C., Kamiki, J., António, P., Figueiredo, N., Carvalho, C. T., Castillo-Martín, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.592031 · Cited by 17 · see citing works
A translational concept of immuno-radiobiology
Lippitz, B. E., & Harris, R. A. (2019) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2019.06.001 · Cited by 18 · see citing works
Self-citationAarstad, H. H., Moe, S. E., Bruserud, Ø., Lybak, S., Aarstad, H. J., & Tvedt, T. H. A. (2020) · Biomedicines · doi:10.3390/biomedicines8100418 · Cited by 18 · see citing works
Bouaouiche, S., Ghione, S., Sghaier, R., Burgy, O., Racoeur, C., Dérangère, V., Bettaı̈eb, A., & Plenchette, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168449 · Cited by 18 · see citing works
Interleukin-6-174G>C gene promoter polymorphism and prognosis in patients with cancer
Zhai, K., Yang, Y., Gao, Z.-G., & Ding, J. (2017) · Oncotarget · doi:10.18632/oncotarget.17771 · Cited by 17 · see citing works
Tong, H., Feng, H., Hu, X., Wang, M., Song, Y., Wen, X., Li, Y., & Wan, X. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.544248 · Cited by 17 · see citing works
Investigation of TNF-α and IL-6 Levels in the Sera of Non-Melanoma Skin Cancer Patients
Ghahartars, M., Abtahi, S., Zeinali, Z., Fattahi, M. J., & Ghaderi, A. A. (2021) · Iranian Biomedical Journal · doi:10.29252/ibj.25.2.88 · Cited by 17 · see citing works
Decreased Mean Platelet Volume is Associated with Cervical Cancer Development
Shen, W. J., Fu, S., Li, N., Li, L. L., Cao, Z., Li, C., Liu, T., & Wang, R.-T. (2017) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2017.18.7.1769 · Cited by 17 · see citing works
Janiczek-Polewska, M., Szylberg, Ł., Malicki, J., & Marszałek, A. (2022) · Biomedicines · doi:10.3390/biomedicines10071600 · Cited by 16 · see citing works
- Authors
- Lippitz, B. E., & Harris, R. A.
- Affiliations
- Karolinska University Hospital (SE)
- Corresponding author
- Lippitz, Bodo E.
- Venue
- OncoImmunology
- Publisher
- Informa UK Limited
- Published
- 2016-05-03
- Volume
- 5
- Issue
- 5
- Pages
- e1093722
- ISSN
- 2162-4011 (ISSN-L)
- 2162-402X
- PMC
- PMC4910721
- OpenAlex
- W2365037335
- Cited by
- 248
- References
- 165
- Citations by year
- 2026: 21 · 2025: 21 · 2024: 33 · 2023: 19 · 2022: 35 · 2021: 30 · 2020: 28 · 2019: 29 · 2018: 16 · 2017: 16
- FWCI
- 2.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- OncoImmunology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- interleukin-6, serum IL-6, cancer prognosis, cancer survival, cytokine network, tumor microenvironment, immunosuppression, tumor stage, metastasis, cancer immunotherapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
